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Abstract
We present the genetic analyses conducted on a three-generation family (14 individuals) with three members affected with
isolated-Hirschsprung disease (HSCR) and one with HSCR and heterochromia iridum (syndromic-HSCR), a phenotype
reminiscent of Waardenburg-Shah syndrome (WS4). WS4 is characterized by pigmentary abnormalities of the skin, eyes and/
or hair, sensorineural deafness and HSCR. None of the members had sensorineural deafness. The family was screened for
copy number variations (CNVs) using Illumina-HumanOmni2.5-Beadchip and for coding sequence mutations in WS4 genes
(EDN3, EDNRB, or SOX10) and in the main HSCR gene (RET). Confocal microscopy and immunoblotting were used to assess
the functional impact of the mutations. A heterozygous A/G transition in EDNRB was identified in 4 affected and 3
unaffected individuals. While in EDNRB isoforms 1 and 2 (cellular receptor) the transition results in the abolishment of
translation initiation (M1V), in isoform 3 (only in the cytosol) the replacement occurs at Met91 (M91V) and is predicted
benign. Another heterozygous transition (c.-248G/A; -predicted to affect translation efficiency-) in the 59-untranslated region
of EDN3 (EDNRB ligand) was detected in all affected individuals but not in healthy carriers of the EDNRB mutation. Also, a de
novo CNVs encompassing DACH1 was identified in the patient with heterochromia iridum and HSCR Since the EDNRB and
EDN3 variants only coexist in affected individuals, HSCR could be due to the joint effect of mutations in genes of the same
pathway. Iris heterochromia could be due to an independent genetic event and would account for the additional
phenotype within the family.
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Background
Waardenburg-Shah syndrome, Waardenburg-Hirschsprung
disease or Type IV Waardenburg syndrome (WS4; MIM
#277580) is a congenital developmental disorder characterized
by pigmentary abnormalities of the skin, eyes and/or hair,
sensorineural deafness and aganglionosis of variable portions of
the colon (Hirschsprung disease) [1]. WS4 is rare, with an
incidence of ,1/40,000–1/50,000 live-births, and occurs in all
races. To the best of our knowledge, there are only 74 WS4 cases
described (2012) in the English literature [2,3,4,5,6,7,8]. WS4 can
occur sporadically or it segregates in families in an autosomal
dominant or recessive inheritance pattern with reduced pene-
trance [8,9].
WS4 is underlain by homozygous or heterozygous coding
sequence (CDS) mutations affecting any of the three following
genes, EDN3 (20q13.2–q13.3), encoding the endothelin-3 peptide;
EDNRB (13q22), encoding its receptor; and SRY (Sex determining
region Y)-box 10 (SOX10) (22q13.1), encoding a transcription
factor [8,10]. Chromosomal abnormalities involving the regions
where these genes map have also been described. These genes
regulate the proliferation, migration and differentiation of the
neural crest cells (NCCs) from which melanocytes, enteric and
peripheral neurons derive. In human, SOX10 CDS mutations
account for about 50% of the WS4 patients and CDS mutations in
EDN3 or EDNRB for 20–30% of the WS4 patients [8]. However,
15–35% of the WS4 patients are devoid of CDS mutations in these
3 genes suggesting that mutations either in regulatory regions or
CDSs of other genes may also lead to this disorder. Recently, a de
novo deletion encompassing SOX10 regulatory elements have been
identified in a WS4 patient with no CDS mutations, underscoring
the relevance of regulatory sequences in rare disorders [11]. In
addition, the intra- or inter- familial variability of the phenotype
PLOS ONE | www.plosone.org 1 June 2013 | Volume 8 | Issue 6 | e66631
and incomplete penetrance observed in patients with mutations in
the known WS4 genes, also suggest the involvement of additional
unknown loci that may modify the effect of the mutations in the
main WS4 genes.
Importantly, heterozygous mutations in EDNRB or EDN3 are
also known to cause isolated HSCR [12,13]. Moreover, genetic
interaction between EDNRB and RET, (the main HSCR gene)
[14,15] has been described in a kindred segregating both, isolated
HSCR and WS4 [16] as well as in families or sporadic patients
with isolated-HSCR [17,18,19]. The fact that two mutated genes
are needed for the manifestation of the disease also implies
functional interaction, with additional molecules or ‘‘mediators’’
mediating the link between the RET and EDNRB signaling
pathways [20]. Interactions between Sox10, Edn3 and Ednrb during
enteric nervous system and melanocyte development have also
been described [21] in mice. Indeed, the complexity and
phenotypic variability already observed in genetically heteroge-
neous or oligogenic congenital disorders can be conceptually
understood in the light large range of molecular and cellular
interactions that take place during development. Thus, DNA
alterations in any of the genes codifying for the signaling molecules
that govern the fate of the melanocytes and enteric neurons
precursors may represent a primary etiology for WS4. The WS4
phenotype may therefore result from i) single severe DNA
alterations in coding or non-coding sequences of any genes
encoding crucial molecules; ii) the combinatory effects of less
severe mutations in several genes; iii) the former and the later
combined. The existence of non-clinically affected individuals
carrying mutations in major genes invokes a compensatory effect
by other genes.
Here we present candidate gene screening, haplotype and copy
number variation analyses on a three-generation family segregat-
ing Hirschsprung disease and WS4 features. We observed that
while heterozygous mutations in two genes of the same pathway
only coexisted in HSCR-affected individuals, a de novo CNV could
account for the heterochromia iridum phenotype presented by the
only family member displaying WS4 features.
Materials and Methods
Pedigree
A non-consanguineous three-generation white Brazilian family
of European ancestry (14 individuals) with Hirschsprung pheno-
type was included in this study. Out of the fourteen individuals,
three (II-1, II-3, III-3) were only affected with the most severe type
of Hirschsprung disease (long segment aganglionosis; L-HSCR)
and one (II-5) was affected with L-HSCR and complete
heterochromia iridum (Figure 1). Adult family members gave
written informed consent and for minors, written informed
consent was obtained from their parents. The study was approved
by the institutional review board of The University of Hong Kong
together with the Hospital Authority (IRB:UW06-349/T/1374).
II-1 was born in 1965 with Hirschsprung disease from
unaffected non-consanguineous parents. Duhamel procedure was
performed in 1966, when he was 17 months old. Complications
following the operation included stenosis and fistulas and, an
emergency colostomy was performed. Finally, after a Soave
operation, the patient was discharged (in 1968) in excellent
conditions. Colonic biopsy showed aganglionosis. II3, born in
1968, was medically treated until the age of 3, when she was
submitted to a Soave operation (without colostomy) and finally
diagnosed with L-HSCR. II5 was born (1970) with complete
heterochromia iridum (the 2 irides are of different color, one blue
and the other brown) and L-HSCR. He was treated medically till
he was 3 years old when he was also submitted to a Soave
procedure without colostomy. Colonic biopsy showed aganglio-
nosis. III-3 born in 2007 with L-HSCR, was operated at the age
of 15 months. Colonic biopsy showed aganglionosis. III-3 has two
siblings, III-1, a male born in 1994 with no HSCR or WS4
features, and III-2, a girl (born in 2004) who died aged 10 months.
III-2 was born with myelomeningocele and megacolon. She
developed post operatory mild hydrocephalus and passed away to
septicaemia and urinary infection. No DNA sample is available
from this family member. This is the only family member who had
neurological problems.
Except for II5, no pigmentation anomalies were observed in
any of the family members. Also, none of the individuals had
sensorineural hearing impairment nor developmental/growth
delay or dysmorphic features.
DNA sequence analysis
Direct sequencing of coding regions. Polymerase chain
reaction (PCR) amplification and direct sequencing were used to
screen for DNA variations in the coding and the 59 and 39 flanking
regions of the known WS4 candidate genes EDN3, EDNRB,
SOX10, as well as those of RET (the main HSCR gene). For the
latter, the RET intron 1 SNP (rs2435357), highly associated with
HSCR and known to interact with EDNRB [18] was also amplified
and sequenced. Primers and PCR conditions are described
elsewhere [22,23,24].
SNP genotyping array and CNV predictions. The 14
individuals were genotyped on the Illumina HumanOmni2.5-
Quad Beadchip, which contains 2,443,177 markers throughout
the genome. This allowed us to i) verify the familial relationships;
ii) assess the presence of CNVs; iii) obtain accurate haplotypes.
Calls were provided by the Centre for Applied Genomics
(TCAG; www.tcag.ca; Toronto, Canada). CNV segments were
predicted by two programs, PennCNV [25] and QuantiSNP [26],
which are two most efficient and publicly available CNV calling
algorithms for Illumina data [27]. Both programs implement
hidden Markov models based on normalized probe intensity value
against expected intensity in terms of Log2 R ratio and relative
allelic copy in terms of B allele frequency. PennCNV integrates
additional information in CNV prediction (i.e. population allele
frequency and distance between adjacent SNPs). .
To obtain high-confidence calls, we only used the overlapping
region of CNVs called by both programs. Before selecting the
overlapping CNV regions, quality control were done separately
(please refer to supplementary materials for details).
Haplotype reconstruction
The most likely haplotypes of the pedigree members were
constructed using MERLIN [28]. The MERLIN haplotype output
files were visualized with HaploPainter [29].
Generation of expression constructs
Wild-type EDNRB variant 1 cDNA (RefSeq: NM_000115.1)
cloned in a pCMV6 expression vector (pCMV6-EDNRB-v1-GFP)
with a variant of green fluorescent protein tag at the C-terminal
end (Turbo-GFP; Origene) and an empty pCMV6-GFP expres-
sion vector were obtained from Origene Technologies (Rockville,
MD, USA). Reverse transcription PCR (RT-PCR) was performed
to isolate full-length coding region of EDNRB variant 4 (RefSeq:
NM_001201397; isoform 3) from human melanoma cell lines and
ligated into pGEM-T Easy vector (Promega). Primers with Sgf I
and Mlu I restriction sites were designed to amplify full-length
coding regions of EDNRB variant 4 (RefSeq: NM_001201397)
which was then subcloned to pCMV6 entry vector to generate a
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pCMV6-EDNRB-v4-GFP vector. The EDNRB mutations vectors
pCMV6-EDNRB-v1-M1V-GFP (M1V for isoforms 1) and
pCMV6-EDNRB-v4-M91V-GFP (M91V for isoform 3) were
generated by site-directed mutagenesis using the QuickChange
XL Site-Directed Mutagenesis Kit (Stratagene) according to the
manufacturer’s instructions. All the DNA fragments were verified
by direct sequencing. Primer sequences are available upon request.
Cell lines and Transfection
Human Embryonic Kidney 293 cells (HEK293, Invitrogen)
were grown in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% fetal calf serum (FBS), penicillin (100 U/
ml) and streptomycin (100 mg/ml) at 37uC with the presence of
5% CO2. Cells were seeded in culture wells 24 hours prior to
transfection. The plasmids, pCMV6-AC-GFP (empty vector),
pCMV6-AC-EDNRB-v1-GFP (wild-type EDNRB isoform 1),
pCMV6-AC-EDNRB-v4-GFP (wild-type EDNRB isoform 3),
pCMV6-AC-EDNRB-v1-M1V-GFP (M1V) and pCMV6-AC-
EDNRB-v4-M91V-GFP (M91V), were transfected into HEK293
cells according to LipofectamineH 2000 transfection reagent
(Invitrogen) instructions.
Immunofluorescence
HEK293 cells (26105), grown for 24 h in each 35 mm Petri-
dish with 14 mm Bottom Microwell No. 1.5 coverglass (MatTek,
USA), were transfected with 1.5 mg empty vector, wild-type
EDNRB isoform 1, wild-type EDNRB isoform 3, M1V and M91V
using LipofectamineH 2000 transfection reagent (Invitrogen). The
living cells were incubated overnight and GFP fluorescence were
observed directly on the chamber slide under confocal laser
scanning using a Zeiss LSM 700 confocal laser-scanning
microscope (lex = 488 nm,lem.515 nm). Fluorescence intensity
was measured using the eight-bit gray scale of the LSM 700
software.
Results and Discussion
Pedigree: pattern of inheritance
We considered the mode of inheritance or genetic mechanism
that might give this pattern of affected family members. Two
unaffected parents (I-1, I-2) had three affected children (II-1, II-3,
II-5), one of whom (II-1) passed down the phenotype to two
individuals (III-2, III-3) of the third generation in an apparently
autosomal dominant manner. If that was the case, it would
imply that one of the parents carried a mutation that, for whatever
reason, was not fully penetrant. Other possibilities considered were
i) one of the parents carried a balanced translocation that
became unbalanced in the children in which case, miscarriages
and multiple malformations in multiple organs would have been
expected; and ii) autosomal recessive inheritance, in which
case, I-1, I-2 and II-2 would all have to be carriers for the same
autosomal recessive disease, which is extremely unlikely as this is a
non-consanguineous family. Yet, the transmission of WS4 is
described as neither fully recessive nor fully dominant. WS4
patients with different pathogenic mutations in the same gene
(compound heterozygotes) have also been described [8].
Importantly, while only II-5 (heterochromia iridum) and III-2
(neurological problems) have with characteristics of WS4, the rest
of the affected family members manifest isolated HSCR.
After all these considerations, we set out to investigate the
genetic lesions underlying this variable phenotype. To this end,
and, to cover all possibilities, the 14 family members were screened
for small variations in the coding regions of i) the WS4 candidate
genes; ii) the main HSCR gene; and iii) CNVs through the
genome as deletions encompassing the candidate genes have been
reported and translocations could also be considered in spite of all
of the above.
No SOX10 deleterious variants
Sequencing of the complete CDS of the SOX10 gene did not
reveal any damaging variant that could have explained the
phenotype. Two SNPs leading to synonymous changes were
Figure 1. Pedigree of the three-generation family included in this study. Slash: deceased. Solid black: individuals affected with HSCR only.
Green: individual affected with HSCR and heterochromia iridum. Yellow: individual affected with HSCR and meningocele. + indicates EDNRB c.1A.G; *
indicates EDN3 c.-248G.A.
doi:10.1371/journal.pone.0066631.g001
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identified in non-affected members of the family (Table 1). These
SNPs, rs73415876 (p.Y83Y) and rs139884 (p.H309H) have a
global Minor Allele Frequency of 0.033 and 0.287 respectively.
Identification of a heterozygous mutation in EDNRB
Sequencing of the complete CDS of the EDNRB gene revealed a
c.1A.G heterozygous DNA change in the NM_000115.3
sequence. The DNA variant was not only found in all affected
individuals (II-1, II-3, II-5, III-3) but was also present in three
unaffected individuals (I-2, III-5, III-7) (Table 1; Figure 1).
c.1A.G was passed down to the family members by the
unaffected mother (I-2). This variant was not present in any of
the databases searched (NCBI, dbSNP137, 1000 Genomes Project
–release 13, December 2012-). This variant resulted in the
replacement of the translation initiation codon methionine (Met)
with a valine (Val) in the EDNRB isoforms 1 and 2 (NP_000106.1
and NP_003982.1; 442 and 436 amino acids, respectively) and
such replacement (M1V) would theoretically abolish the use of the
translation initiation codon (ATG-GTG, M1V). However, in
EDNRB isoform 3 (NP_001188326.1; 532 amino acids) the
replacement is at Met91 (M91V) and is predicted benign by
PolyPhen [30].
At this point, the only explanation we could provide is that of
reduced pentrance as direct sequencing of the other WS4
candidate genes or RET did not reveal any pathological mutation
in their CDSs. Yet, we formulated several hypothesis to account
for the intra-familial phenotypic variability: i) since different
EDNRB transcripts are expressed concomitantly (at least in the still
developing newborn’s gut [31] the phenotype manifestation could
depend on the relative expression amounts of the mutated
EDNRB isoforms (benign/damaging) at a given time point during
the embryonic stages, provided that all isoforms play a similar role
on neural crest cell development –enteric neurons/skin melano-
cytes-; ii) in carriers, in spite of having the initiation codon (M1V)
mutated in isoform 1 and 2, the protein is translated using an
alternative translation start site and the resulting protein, although
shorter, still is functional [32]; iii) while the amount of protein
expressed from the wild-type EDNRB allele is sufficient to maintain
proper signalling in healthy carriers, it does not reach the
necessary threshold for signalling in affected individuals; and/or
iv) differential allelic expression (or imprinting) between carriers
and affected individuals exists. Thus, variance in expression levels
at different time points could account for the intra-familial
variability, including that of individual II-5. Yet, no matter which
of the mechanism hypothesized is proved or disproved, there must
be additional genetic factors to account for the reduced penetrance
of this mutation and the intra-familial variability of the phenotype.
For obvious reasons, these postulations cannot be fully tested.
Nevertheless, we set out to explore some of the possibilities
mentioned with regards to the EDNRB mutation.
The M1V mutation abolishes the EDNRB isoform 1. To
investigate the translocation of the mutant EDNRB proteins
within cells, we transiently transfected equal amounts (20 mg) of
the wild-type or M1V mutant GFP-tagged EDNRB isoform 1 into
HEK293 cells and analysed by confocal microscopy.
In cells transfected with wild-type EDNRB isoform 1/GFP,
signals were detected at the plasma membrane only (Figure 2A).
This indicates that EDNRB isoform 1 protein translocated to the
cell surface and fulfilled its functional property as a cell surface
receptor. On the other hand, the mutant EDNRB isoform 1
(M1V) displayed a clustered localization in the cytosol and a
significantly reduced intensity on the membrane when compared
with the wild-type (Figure 2A). Our interpretation is that the
mutation (M1V) abolishes the translation start site and that the
mutated RNA could have been translated through an alternative
translation initiation codon. Sequence inspection revealed that the
alternative translation initiation codon is likely to be located
between Gly26 and Arg64, where, within a sequence compatible
with the Kozak consensus, there is a methionine in codon 46
(Met46). Thus, a shorter protein, that could not translocate onto
the membrane due to the lack of the signal peptide, could have
been generated and account for our observations. Reduced
amount of EDNRB receptor might alter the signalling pathway
and hence, the differentiation and development of neural crest
cells could be affected.
Role of the EDNRB isoform 3. We then investigated
whether indeed the mutation was innocuous to EDNRB isoform
3 as predicted by PolyPhen. Confocal microscopy showed that
both wild-type EDNRB isoform 3 and mutant EDNRB isoform 3
(M91V) were imperceptible on the plasma membrane (Figure 2B),
which implies that this isoform may not function as a cellular
receptor. We then resorted to TargetP 1.1 [33] and MitoProt II
Table 1. Sequence variants of EDNRB, EDN3, RET and SOX10 identified.
Gene and exon Nucleotide change (s)
Codon position and
amino acid change Individuals
EDNRB
Exon 1 c.1A/G M1V I-2, II-1, II-3, II-5, III-3, III-5, III-7
Exon 6 c.831A/G (rs5351) L277L I-1, II-1, II-3, II-4, II-6, III-1, III-3, III-4, III-5, III-6, III-7
EDN3
59UTR c.-248G/A I-1,II-1, II-3, II-5, III-3, III-4
RET
Exon 2 c.135G/A (rs1800858) A45A I-1, I-2, II-1, II-2, II-3, II-5, II-6, III-1, III-3, III-4, III-5, III-6, III-7
Exon 7 c.1296A/G (rs1800860) A432A I-2, II-2, II-3, II-5, II-4, II-6, III-1, III-3, III-4, III-5, III-6, III-7
Exon 13 c.2307T/G (rs1800861) L769L I-1, I-2, II-1, II-3, II-4, II-5, III-1, III-3, III-4, III-5, III-6, III-7
SOX10
Exon 2 c.249C.T (rs73415876) Y83Y II-6
Exon 4 c.927T.C (rs139884) H309H II-6, II-4, III-6, III-7
In bold: HSCR affected individuals; In italics: individual affected with WS4.
doi:10.1371/journal.pone.0066631.t001
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v1.101 [34] for in silico prediction of the EDNRB isoform 3
subcellular location (Table S1). TargetP assigns the location in
accordance with the predicted presence of any of the N-terminal
presequences including mitochondrial targeting peptide (mTP)
and secretory pathway signal peptide (SP) and MitoProt is
designed to identify mitochondrial signal sequences. Both
programs predicted the presence of a 115 residues long mTP in
the N terminal of EDNRB isoform 3 (Figure S1). Moreover,
according to MitoProt, the probability of being exported to
mitochondria hardly differed between the wild-type and mutated
EDNRB isoform3 (92.41% and 89.60% respectively). Importantly,
no mTP were predicted for EDNRB isoforms 1 or 2. Therefore, it
would appear that M91V would not affect the putative role of the
EDNRB isoform 3 in the cytoplasma organelle. Thus, the EDNRB
isoform 3 might not play a role as a cellular receptor and,
consequently, nor in the EDNRB signaling controlling the neural
crest cells fate.
While we cannot demonstrate whether variation in expression
levels of EDNRB isoform 1 (mutated or while type) during
development played a role in the manifestation of the phenotype,
it seems that postulations i) and ii) are to be dismissed. Still, the
effect of more than one gene is patent by the transmission and
variability of the phenotype in this family.
No interaction between RET and EDNRB alleles in this
family
Given the significant association between the transmission of the
EDNRB Trp276Cys mutation and an HSCR-susceptibility RET
haplotype reported in HSCR-trios [18] as well as the finding of
two functionally significant EDNRB and RET mutations in a
patient with isolated HSCR [19], we investigated the CDS of the
RET gene and the HSCR-risk haplotype in all 14 family members.
No RET CDS pathological variants or mutations were detected
in these individuals. Next, to find out whether a link could be
established between the presence of the RET risk haplotype and
the EDNRB mutation with regards to the penetrance of the latter,
we constructed 4 markers RET haplotypes and investigated their
transmission within the family (Figure S2). The RET risk
haplotype consists of the HSCR-associated alleles ‘‘TAGG’’ of
rs2435357; rs1800858, rs1800860, and rs1800861 polymorphisms.
Importantly, it has been shown that rs2435357T allele (RET
intron 1) as well as the RET risk haplotype are linked to reduced
RET expression both in vitro and in vivo [35,36,37]. Therefore, the
joint presence of the EDNRB mutation and the RET risk haplotype
in affected individuals could account for the phenotypic differences
between healthy and affected EDNRB mutation carriers. Yet, we
found that the RET risk haplotype (both in homo- and
heterozygosis states) was indistinctly present in affected and non-
affected carriers as well as in non-carriers (Figure S2). Therefore,
it seems that the phenotypic variability cannot be explained by the
interaction of these two RET and EDNRB alleles.
Joint effect of the EDNRB and EDN3 alleles
As no CDS pathogenic variants had been found in EDN3, we
paid attention to a G to A change (c.-248G/A) in the 59
untranslated region (59UTR) of the gene. Importantly, all
affected individuals carrying the EDNRB mutation (II-1,
II-3, II-5 and III-3; Figure 1) also had this EDN3 variant. The c.-
248G/A EDN3 change was not present in healthy EDNRB
carriers (III5, III7) but present in two healthy non-carriers, one of
whom, I-1 (unaffected father) passed it down. Haplotype
reconstruction (Figure S3) clearly showed the transmission of
the -248G/A EDN3 variant in the pedigree from the unaffected
father (I-1). This EDN3 variant is not reported in dbSNP137, or in
the 1000 Genomes Project database (release 13, December 2012).
As post-transcriptional regulation is mediated by cis-acting
regulatory motifs in the 59 and 39UTRs, we used bioinformatic
tools to find out if the c-248G/A overlapped with any of such
motifs and whether the replacement of a G with an A would be
detrimental. Importantly, the -248G/A transition occurred in a
highly evolutionary conserved site (Figure S4). Such degree of
conservation for a non-translated base suggests that this 59UTR
guanine may be critical for the binding of regulatory proteins, and
any disruption of this process would destabilise the mRNA and/or
affect translation efficiency. While according to ENCODE , this
position resides in the binding site of transcription factor SUZ12,
JASPAR, a transcription factor binding profile database http://
jaspar.genereg.net/ did not identify any on the site itself, but
several in the neighbourhood. Thus, the variant might reduce
access to those neighboring predicted sites. Next, to investigate if -
248G/A could interfere with RNA folding, hence, affect the
overall regulation process, we used Mfold [38] to simulate the
RNA structures with either allele. The allele A lead to a strikingly
different RNA structure that that of allele G (Figure S5).
Figure 2. Localization of C-terminally GFP-tagged EDNRB
fusion proteins in HEK293 cells. A: HEK293 cells were transiently
transfected with wild-type EDNRB isoform 1 (Iso 1) or mutant EDNRB
isoform 1 (M1V). Signals were observed at the plasma membrane in
cells expressing wild-type isform 1 while signals were detected in the
cytosol in cells transfected with mutant isoform 1. B: HEK293 cells were
transiently transfected with wild-type EDNRB isoform 3 (Iso 3) or mutant
EDNRB isoform 3 (M91V). Signals were found in the cytosol in cells
transfected with either wild-type or mutant isoform 3. C. HEK293 cells
were transiently transfected with GFP vector only. Shown are the
representative iamges. Bars, 50 mm.
doi:10.1371/journal.pone.0066631.g002
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Altogether, data suggest that the c-248 G/A transition may affect
the EDN3 expression levels. Functional studies on this EDN3
variant were not performed. Regulatory functional activity may
vary from to cell to cell type and even if the EDN3 variant were
functional in vitro, we would never be able to ascertain its function
in vivo, especially given the relevance of spatial-temporal regulation
during developmental stages.
Importantly, Kenny and colleagues reported lower EDN3
mRNA levels in ganglionic and aganglionic gut of HSCR patients
devoid of CDS mutations compared to those in gut of non-HSCR
individuals and suggested EDN3 transcriptional deficit as a possible
cause of aganglionosis [39].
Given that the EDNRB and EDN3 variants only coexist in
affected individuals (with both the EDNRB receptor and its ligand
EDN3 compromised), it would appear that their joint effect is
needed for the phenotype to manifest. This is in line with the
essentiality of the interaction between EDN3 with ENDRB for the
development of epidermal melanocytes and enteric neurons [40].
Thus, it is tempting to speculate that the transmission of the trait
results from two independent mutations in two different genes of
the same pathway. This family would exemplify a case of non-
allelic non-complementation which occurs when recessive muta-
tions in two different loci fail to complement one another and
consequently, the double heterozygote exhibits a phenotype.
Importantly, such mechanism has already been described in
HSCR [17,18].
Yet, while all individuals carrying both the EDNRB and the
EDN3 heterozygous mutations have virtually the same HSCR
phenotype (isolated long segment), only one (II-5) member of the
family has pigmentation problems. After an exhaustive literature
search, we identified only three reports of HSCR patients with
heterochromia iridum as the sole associated anomaly [41,42]. No
mutation screening had been done.
The EDNRB and EDN3 mutations reported here have been
submitted to the Leiden Open Variation Database (LOVD) v.3.0.
CNV analysis
We also scanned the whole genome for rare CNVs. A total of
529 CNV regions and two chromosomal aberrations
(CNV.1 Mb) were identified in this family. The chromosomal
aberrations were transmitted by non-affected individuals to also
non-affected individuals.
Of the 529 CNVs identified, 160 intersected with genes (genic-
CNVs; 131 genes disrupted) and 369 CNVs were in non-coding
regions of the genome. Among the genic-CNVs, 18 CNVs (35
genes disrupted) were present in at least one affected individual but
also in unaffected family members. Likewise, among the non-genic
CNVs, 62 were present in at least one affected individual but also
in unaffected family members.
As a CNV reported in a healthy individual would be less likely
to be pathogenic, all CNVs present in at least one affected
individual were checked against the Database of Genomic
Variants (DGV), a catalog of structural variations gathered from
the analysis of 11,943 healthy individuals. All but 26 CNV regions
(37 CNVs) and all chromosomal aberrations identified in this
family had been also been detected among the DGV controls.
None of the CNVs (including those no reported in DGV) were
shared by the four affected individuals and carriers of the
EDNRNB or EDN3 mutations. Our data ruled out a direct role
of CNVs in this familial disorder. Expectedly, no CNVs
encompassing any of the WS4 candidate genes were detected.
Since II-5 is the only family member born with heterochromia
iridum in addition to HSCR, we considered the possibility of the
pigmentation problem being due to a genetic event independent of
the EDNRB/EDN3 mutations harboured by this individual.
We made use of the data provided by the CNV analysis to
search for any specific feature that could account for the
heterochromia iridum in that individual, bearing in mind that
the search for another genetic lesion would require the scrutiny of
the whole genome and that therefore, our CNV analysis is limited.
Thus, we inspected the CNV profile of individual II-5 and paid
attention to de novo or inherited CNVs that were not
present in any other family members (except for II-5
parents; I-1 and I-2) and had not been passed down to
the next generation. II-5 had 5 genes intersected by CNVs, 2 of
which were de novo and 4 inherited (Table S2). Except for ALDH2,
these genes were not only reported intersected in DGV but also in
the Database of Chromosomal Imbalance and Phenotype in
Humans Using Ensembl Resources (DECIPHER), which contains
data on over 10,000 patients suffering from developmental
disorders who harbor submicroscopic deletions or duplications.
Interestingly, one of the de novo CNV duplication (45.5 kb)
involved DACH1 (dachshund homolog 1 (Drosophila); Attenuation
of Forkhead signaling by the retinal determination factor), a
gene in chromosome 13q22 (6 Mb apart from EDNRB) reported
deleted in Decipher patients affected with fullness of peri-orbital
region or retinoblastoma. As for the non-genic CNVs present in II-
5, we identified 3 inherited and 10 de novo CNVs (Table S3).
Among the latter, a 38.5 kb duplication and a 20.9 kb deletion
were detected in chromosome 13, 16.7 and 15.3 Mb upstream
DACH1 respectively. Importantly, iris heterochromia has been
reported in a 13q-deletion syndrome patient without HSCR [43]
as well as in infants with retinoblastoma. Whether these CNVs
affecting DACH1 or surroundings in chromosome 13q contribute
to heterochromia iridum is unknown.
Overall, many of the CNVs reported in DGV are also reported
in DECIPHER patients which indicate that the contribution of
each CNV to the phenotype, if any, would be limited to the
individual bearing them and this could account for the intra-
familial variability observed, as exemplified by the phenotype
presented by individual II-5. Of course, we cannot prove or
disprove whether heterochromia iridum results from the CNVs
unique to II-5 or/and from the EDNRB/EDN3 mutations as
reported in other patients with WS4. These CNVs may affect
regulatory regions anywhere in the genome offsetting the
synchronization and balance of the signaling network implicated
in the disorder. Also, it should be born in mind that the
heterochromia iridum phenotype could be due to a genetic
mosaicism, that is, an independent event occurred during
developmental stages, affecting only the embryonic cell lineage
from which the eye pigmentation cells derive (in which case, we
could not have detected the genetic lession).
In sum, our exhaustive genetic analysis shows that, in this Brazilian
family of European ancestry, the manifestation of the HSCR
phenotype may require mutations in two genes of the same pathway.
The additional feature -iris heterochromia- presented by one affected
individual could have resulted from an independent genetic event,
such a de novo CNV affecting genes involved in eye development.
Supporting Information
Figure S1 Genomic structure and differential splicing
of human EDNRB gene. Black arrow indicates the ATG start
site for isoform 3. Red arrow indicates the ATG start site for
isoform 1 and 2 and is the location of the mutation found in the
Brazilian family. SP: signal peptide.
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Figure S2 The most likely RET haplotypes of the
pedigree (A, C, G, T to 1, 2, 3, 4). Individuals carrying the
EDNRB mutation are indicated.
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Figure S3 The most likely EDN3 haplotypes of the
pedigree were shown (A, C, G, T to 1, 2, 3, 4). It showed
that the c.-248G/A variation was transmitted from the I-1 and
shared by all four affected individuals, II-1, II-3, II-5, and III-3
and one unaffected individual III-4.
(DOCX)
Figure S4 Nucleic acid multiple sequence alignment of
mammalian 59UTR of EDN3. The UCSC genome browser
was used to identify sequence conservation features in the 59UTR
of EDN3. The red rectangle indicates the nucleotide c.-248G and
it is highly conserved among species.
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Figure S5 Predicted RNA secondary structures for the
wild-type and mutated (-248G/A) 59UTR of the EDN3.
The GGGGUGGU structure in the mutated 59UTR of the EDN3
formed a loop instead of a stem compared in the wild-type 59UTR
of the EDN3.
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Table S1 TargetP 1.1 server prediction results. Subcel-
lular locations of different EDNRB isoform proteins were
predicted by using TargetP 1.1 server. SP, a signal peptide;
mTP, a mitochondrial targeting peptide; M, Mitochondrion; S,
Secretory pathway; RC: Reliability class, from 1 to 5, where 1
indicates the strongest prediction.
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Table S2 Genes disrupted by CNVs in II-5.
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